A hybrid strategy to enhance small-sized upconversion nanocrystals
Biosensors and Bioelectronics · 2025-03 · 271 · 117003
DOI: 10.1016/j.bios.2024.117003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2025-03. Verfasst von Yijun Luo und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Bioresources Chemical and Materials Engineering, Shaanxi University of Science & Technology, Xi'an, 710021, Shaanxi, China. Hauptthemen laut MEDLINE: Nanoparticles, Rhodamines, Biosensing Techniques. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 65 Literaturangaben.
Abstract (Originalsprache)
Upconversion nanoparticles (UCNPs) are characterized by high photostability, narrow spectral bands, excellent tuneability, and low biotoxicity, facilitating a broad range of biomedical applications. However, the small size required in many biological applications implies a lower luminescent brightness, as large surface-to-volume ratio is always accompanied with severe surface quenching. Herein, we introduce a strategy to overcome the surface quenching by incorporating an acceptor dye, sulforhodamine B (SRB) to surpass energy relaxation on long-lived lanthanide excited states. The surface modification of SRB led to up to 98.8% energy transfer efficiency, accompanied with the emergence of an intense SRB emission, with four orders of magnitude of change in the SRB/UCNPs emission ratio. The further structural optimisation led to an 8-fold upconversion emission enhancement. Moreover, the system exhibits excellent photostability, with only a 25% reduction over 2 h under intense irradiation. By incorporating a pH responsive 5-carboxytetramethylrhodamine (5-TAMRA) to the UCNPs, we achieved a self-referencing protochromic sensor that are specific to protons and resistant to interference from various metal ions. This work provides a facile method for enhancing small-sized nanocrystals for potential biomedical sensing and imaging applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Bioresources Chemical and Materials Engineering, Shaanxi University of Science & Technology, Xi'an, 710021, Shaanxi, China.
- College of Bioresources Chemical and Materials Engineering, Shaanxi University of Science & Technology, Xi'an, 710021, Shaanxi, China. Electronic address: luoyuxia@sust.edu.cn.
- School of Mathematical and Physical Sciences, Faculty of Science, University of Technology Sydney, Sydney, New South Wales, 2007, Australia.
- Technological Institute of Materials & Energy Science (TIMES), Xi'an Key Laboratory of Advanced Photo-electronics Materials and Energy Conversion Device, School of Electronic Information, Xijing University, Xi'an, 71012…
- Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, Department of Chemistry, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, 200241, China.
- Department of Electronic Materials Engineering, Research School of Physics, The Australian National University, Canberra, Australian Capital Territory, 2601, Australia.
Zitieren
APA
Luo, Y., Luo, Y., Liu, Y., Huang, Y., Yu, P., Ma, H., Li, X., Zhang, Z., Zhang, C., Chen, C., Gale, P. A., & Bao, G. (2025). A hybrid strategy to enhance small-sized upconversion nanocrystals. Biosensors and Bioelectronics, 271, 117003. https://doi.org/10.1016/j.bios.2024.117003
Vancouver
Luo Y, Luo Y, Liu Y, Huang Y, Yu P, Ma H, et al. A hybrid strategy to enhance small-sized upconversion nanocrystals. Biosensors and Bioelectronics. 2025;271:117003. doi:10.1016/j.bios.2024.117003
BibTeX
@article{Luo2025,
author = {Luo, Yijun and Luo, Yuxia and Liu, Yuxi and Huang, Yin and Yu, Ping and Ma, Hao and Li, Xinping and Zhang, Zhao and Zhang, Cuiling and Chen, Chaohao and Gale, Philip A and Bao, Guochen},
title = {A hybrid strategy to enhance small-sized upconversion nanocrystals},
journal = {Biosensors and Bioelectronics},
year = {2025},
volume = {271},
pages = {117003},
doi = {10.1016/j.bios.2024.117003}
}
EUVIMED